Patient experiences with liraglutide for obesity and binge eating disorder-A qualitative study.

ABSTRACT:

Introduction

Obesity is a growing health concern and a known risk factor for binge eating disorder (BED). BED is characterized by episodes of overeating with a loss of control, often leading to psychological distress. In some cases, medication may be recommended to manage depressive symptoms and support weight loss. Liraglutide, a glucagon-like peptide-1 (GLP-1) analog, works by targeting the brain's reward system to reduce psychological stress and enhance feelings of fullness. However, there is limited research on the use of liraglutide for patients with both obesity and BED. This qualitative study aimed to investigate how patients with these conditions experience treatment with liraglutide.

Methods

A qualitative design with individual semi-structured, in-depth interviews w

SUBMITTER: Folling IS 

PROVIDER: S-EPMC12578197 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature